User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
A joint Virtual Live Event for PsychU members in ID, NV, & WY and NephU members in WA, OR, ID, AK, MT, & WY. In this presentation, our speakers will provide a brief overview of the obesity epidemic and how obesity may be a contributing factor to other serious medical conditions, including the potential ramifications […]
Patient empowerment is an important concept in the care of patients with chronic kidney disease. This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance of this collaborative counseling method in this population. By communicating and empowering patients, many outcomes have been shown to improve in chronic kidney disease. This […]
This presentation, Dietary Factors & Polycystic Kidney Disease (PKD): Disease Progression, reviews practical guidance for diet and PKD and focuses on the preclinical and clinical data on the role of body mass index, caloric intake, cholesterol, and caffeine on PKD progression. In this presentation the impact of these dietary factors on the pathophysiology of PKD and […]
Clinical pharmacy services have the potential to contribute significantly to the multidisciplinary team by providing safe, effective, and economic care for patients. Given recent practice developments (e.g. polypharmacy reviews and pharmacist prescribing), there is a need to provide a current synthesis of evidence-based characteristics and outcomes of clinical pharmacy practice in treating patients with chronic […]
Clinical pharmacy services have the potential to contribute significantly to the multidisciplinary team by providing safe, effective, and economic care for patients. Given recent practice developments (e.g. polypharmacy reviews and pharmacist prescribing), there is a need to provide a current synthesis of evidence-based characteristics and outcomes of clinical pharmacy practice in treating patients with chronic […]
A joint Virtual Live Event for PsychU & NephU members in Delaware. There is a high prevalence of depression among patients with chronic kidney disease (CKD). This presentation will examine the clinical overlap between CKD and major depressive disorder (MDD) in symptomatology, behavioral and biological mechanisms, the impact of comorbid depression on CKD outcomes, and […]
Patient empowerment is an important concept in the care of patients with chronic kidney disease. This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance of this collaborative counseling method in this population. By communicating and empowering patients, many outcomes have been shown to improve in chronic kidney disease. *Speakers […]
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. *Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). Jill […]
As part of our Patient Empowerment series, this presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they manage the complexities of their care regimen. Health literacy is crucial for dialysis and transplant patients so they can be empowered to participate in shared […]
In this presentation, the etiology and pathogenesis of hyponatremia (HN) will be discussed. HN is often asymptomatic or the symptoms are confused with other diseases. The symptoms and often severe consequences will be presented along with some general management recommendations. *Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Featured Speakers Location Online […]
In this presentation, the etiology and pathogenesis of hyponatremia (HN) will be discussed. HN is often asymptomatic or the symptoms are confused with other diseases. The symptoms and often severe consequences will be presented along with some general management recommendations. *Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Featured Speakers Location Online […]
Over a year ago, President Donald Trump signed an executive order that has led to the most aggressive push to improve the lives of patients with kidney disease since Congress agreed to pay for life-saving dialysis treatment in 1972. This webinar will explore the progress on that directive and discuss the goals, key regulatory measures, […]
